We've found
31,654
archived clinical trials in
Cardiology
We've found
31,654
archived clinical trials in
Cardiology
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
Click here to add this to my saved trials
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
Click here to add this to my saved trials
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
Click here to add this to my saved trials
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
Click here to add this to my saved trials
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
Click here to add this to my saved trials
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
Click here to add this to my saved trials
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
Click here to add this to my saved trials
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
Click here to add this to my saved trials
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
Click here to add this to my saved trials
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
Click here to add this to my saved trials
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
Click here to add this to my saved trials
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
Click here to add this to my saved trials
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
Click here to add this to my saved trials
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
Click here to add this to my saved trials
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
Click here to add this to my saved trials
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
Click here to add this to my saved trials
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
Click here to add this to my saved trials
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
Click here to add this to my saved trials
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
Click here to add this to my saved trials
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
Click here to add this to my saved trials
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
Click here to add this to my saved trials
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
Click here to add this to my saved trials
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
Click here to add this to my saved trials
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
Click here to add this to my saved trials
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
Click here to add this to my saved trials
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
Click here to add this to my saved trials
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
Click here to add this to my saved trials
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
Click here to add this to my saved trials
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
Click here to add this to my saved trials
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
Click here to add this to my saved trials
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
Click here to add this to my saved trials
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
Click here to add this to my saved trials
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
Click here to add this to my saved trials
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
Click here to add this to my saved trials
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
Click here to add this to my saved trials
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
Click here to add this to my saved trials
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
Click here to add this to my saved trials
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
Click here to add this to my saved trials
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
Click here to add this to my saved trials
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
Click here to add this to my saved trials
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
Click here to add this to my saved trials
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
Click here to add this to my saved trials
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
Click here to add this to my saved trials
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
Click here to add this to my saved trials
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
Click here to add this to my saved trials
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
Click here to add this to my saved trials
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
Click here to add this to my saved trials
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
Click here to add this to my saved trials
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
Click here to add this to my saved trials
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
Click here to add this to my saved trials